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ABSTRACT
Gene expression circuitries, which enable cells to
detect precise levels within a morphogen concen-
tration gradient, have a pivotal impact on biological
processes such as embryonic pattern formation,
paracrine and autocrine signalling, and cellular mi-
gration. We present the rational synthesis of a syn-
thetic genetic circuit exhibiting band-pass detection
characteristics. The components, involving multiply
linked mammalian trans-activator and -repressor
control systems, were selected and fine-tuned to
enable the detection of ‘low-threshold’ morphogen
(tetracycline) concentrations, in which target gene
expression was triggered, and a ‘high-threshold’
concentration, in which expression was muted.
In silico predictions and supporting experimental
findings indicated that the key criterion for function-
al band-pass detection was the matching of
componentry that enabled sufficient separation of
the low and high threshold points. Using the circuit-
ry together with a fluorescence-encoded target
gene, mammalian cells were genetically engineered
to be capable of forming a band-like pattern of dif-
ferentiation in response to a tetracycline chemical
gradient. Synthetic gene networks designed to
emulate naturally occurring gene behaviours
provide not only insight into biological processes,
but may also foster progress in future tissue engin-
eering, gene therapy and biosensing applications.
INTRODUCTION
The quest to understand how temporal and spatial
dynamics at the molecular level give rise to biological
structure and pattern has been a widely pursued goal of
developmental biologists (1–3). Central to these efforts is
the concept of the morphogen which, generally deﬁned, is
any substance that can cause pattern organization by dif-
fusion through a multicellular structure (3). Critically, the
morphogen does not just carry a signal, but rather one
that differs depending on its concentration. Embryonic
pattern formation is an oft-cited example in which
multiple intra-and extra-cellular morphogens have been
identiﬁed, particularly as they relate to Drosophila devel-
opment (4–6). Other examples in which morphogen gra-
dients drive physiological responses include paracrine and
autocrine signalling, the chemoattractant-dependent
control of cell shape and movement, and the impact
of intracellular signalling on cellular structure and
shape (3,7).
According to classic morphogen theory (8), a cell’s
physiological behaviour is the outcome of its interpret-
ation of a single biochemical variable (i.e. morphogen con-
centration) in which interpretation of positional
information is thought to rely on direct, concentration-
threshold-dependent mechanisms. A signiﬁcant body of
work has expanded this classical theory to include a
range of additional mechanisms, such as feedback loops
(9) and multi-interdependent combinatorial morphogen
interactions, that ensure morphogen gradients are ad-
equately regulated and interpreted with sufﬁcient robust-
ness (3,10–11). Staying at the classic level, we sought to
determine whether it is possible to engineer a mammalian
genetic circuitry that is capable of sensing a speciﬁc con-
centration within a morphogen gradient as a pre-condition
for positional-speciﬁcation and subsequent organized
pattern formation.
The creation of synthetic designer gene networks has
been increasingly used to interconnect gene regulation
systems to re-create and gain insights into naturally
occurring gene phenomena. Non-exhaustive examples
include the creation of epigenetic toggle switches (12,13),
oscillatory networks (12,14) and ampliﬁcatory (15),
pulse-generating (16) and band-pass like networks
(17–18). In many cases, these synthetic recreations have
enabled researches to understand the role of speciﬁc gene
control mechanisms, such as negative and forward
feedback, noise and transcriptional cascades, in producing
highly speciﬁc forms of gene expression (19).
In the band-detection network described by Basu et al.,
mathematical analysis was used to design modular com-
ponents that enabled the detection of a low-threshold, a
high threshold and a means of integrating the two
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homoserine lactone (AHL)-dependent transcriptional ac-
tivator, was used to drive expression the cI repressor and
a weakened form of the LacI repressor (LacIM1). The cI
repressor was coupled to a further regulatory cascade
which repressed the expression of wild-type LacI. Both
the weakened and wild-type LacI repressed expression,
to a different extent, of a green ﬂuorescent protein
(GFP) reporter. At low AHL concentrations, LuxR was
not active such that only basal levels of both LacIM1 and
cI repressors were produced. The absence of cI ensured
that wild-type LacI was fully expressed which conse-
quently repressed GFP expression. At high AHL concen-
trations, the LuxR activator drove both high LacIM1 and
cI expression. The presence of cI ensured that wild-type
LacI was completely repressed. However, as sufﬁciently
high concentrations of LacIM1 were expressed, GFP ex-
pression remained nonetheless repressed. It was only at
intermediate concentrations of AHL that a balance was
reached between sufﬁciently low expression of LacIM1 to
prevent LacIM1-mediated repression of PLac, and sufﬁ-
ciently high expression of cI to prevent LacI expression
and consequent LacI-mediated repression of PLac. At this
point, insufﬁcient repression from either LacI repressor
resulted in GFP expression (18).
Whilst prototype studies have been predominantly con-
ducted using prokaryotic systems, the development of
inter-operable gene regulation systems in higher organ-
isms has enabled the successful application of these
efforts to mammalian systems. In addition to providing
validation of underlying theories of natural phenomena,
these applications pave the way for a future generation of
biomedical gene-control technology in which gene expres-
sion is ﬁnely controlled spatially and temporally through
an array of sophisticated synthetic gene control
modalities. In a step-change to standard gradiated on or
off gene control systems [such as the widely popular Tet
system (20)], successfully demonstrated applications
within a mammalian context include toggle and hysteretic
switches (21,22), multi-input logic sensors (23,24),
time-delay circuits (25,26) and oscillatory networks
(27,28).
Employing the relatively well-characterized and
inter-operable tetracycline- (20), macrolide- (29) and
streptrogramin- (30) gene regulation systems as building
blocks, we report the rational design and characterization
of a synthetic gene network exhibiting band-pass process-
ing and output properties. The system utilizes the same
topology as the prokaryotic system described above
involving multiple transcriptional control mechanisms
including autoregulation, and double and triple-level tran-
scriptional cascades. By inter-changing elements of the
network, and by ﬁne-tuning the quantity of interacting
elements, we were able to optimize the network so that
it could be used to sense and respond to a stimuli gradient
whereby gene expression was only evidenced at intermedi-
ate levels of stimuli. We regard to the development of
sophisticated gene networks, such as the band-pass ﬁlter,
and their successful application within high-order organ-
isms as a pre-requisite for future gene therapy strategies
within which gene expression must be highly controlled
and tailorable.
METHODS
Expression vector design and construction
The expression vectors used in this study are depicted in
Figure 1. pDG178 (PhCMV*-1-tTA-pA), in which the
tetracycline-dependent transactivator tTA is expressed in
an autoregulatory manner from a tTA-inducible promoter
(PhCMV*-1), has been previously described (31). pDG200
(PhCMV*-1-E-KRAB-pA), engineered for PhCMV*-1-driven
expression of the erythromycin-dependent transrepressor
E-KRAB; pDG202 (PhCMV*-1-Pip-pA), engineered for
similarly driven expression of the pristinamycin-
dependent transrepressor Pip; and pDG205 (PhCMV*-1-
Pip-KRAB-pA), encoding the pristinamycin-dependent
transrepressor Pip-KRAB again under PhCMV*-1-driven
expression control, were constructed by replacing PSV40
of pWW43 (PSV40-E-KRAB-pA) (29), PhCMV of pMF150
(PhCMV-Pip-pA) (30) and PSV40 of pMF207 (PSV40-
Pip-KRAB-pA) (30), respectively, with PhCMV*-1 from
pMF111 (PhCMV*-1-SEAP-pA) (32) using SspI/EcoRI.
pDG218 (PhCMV*-1-E-pA), in which the erythromycin-
dependent transrepressor E is expressed from PhCMV*-1,
was created by polymerase chain reaction (PCR) ampliﬁ-
cation of E from pWW29 (PhCMV-E-pA) (29) using
primers OWW18 (TACGAATTCCCACCATGCCCCG
CCCCAAGCTCAA; EcoRI site underlined) and
ODG68 (CGTCCGCGTACAGCCGCGCGCAATAAG
CTTGGGAT; HindIII site underlined) primers, followed
by EcoRI/HindIII restriction and cloning into similarly
digested pSAM203 (PhCMV*-1-tTA-IRES-IRES-pA) (33)
to replace tTA-IRES-IRES. pDG237 (PPIRON-E-pA),
encoding E under control of the Pip- or
Pip-KRAB-repressible promoter (PPIRON), was created
by excising PhCMV*-1 from pDG218 and replacing it with
PPIRON excised from pTRIDENT11 (PPIRON-
IRES-IRES-IRES) (34) using SspI/EcoRI. pDG238
(PETRON-Pip) encoding Pip under PETRON expression
control was created by excising PhCMV*-1 and replacing it
with PETRON excised from pWW72 (PETRON-MCS) (35)
using SspI/EcoRI. pBP62 (PPIRON-E-KRAB-pA) (22),
and pWW56 (PETRON-SEAP-pA) (29) encoding SEAP
under control of the E- or E-KRAB-repressible
promoter PETRON, have been previously described.
Similarly, pBP92 (PETRON-Pip-KRAB-pA) (22) and
pMF208 (PPIRON-SEAP-pA) (30) have been previously
described. pND9 (PETRON-Ub
v76-GFP-pA) (36) encodes
aU b
v76 destabilized variant of GFP under PETRON ex-
pression control. pDG295 (PhCMV*-1-Ub
v76-GFP-pA) was
constructed by excising Pip from pDG202 with EcoRI/
NotI and replacing it with Ub
v76-GFP excised from
EcoRI (partial)/NotI digested pND9. pLEGFP-N1
(PhCMV-GFP-pA) and pSEAP2-Control (PSV40-
SEAP-pA) in which GFP and SEAP, respectively, are con-
stitutively expressed were commercially sourced
(Clontech).
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The monoclonal Chinese hamster ovary cell line
(CHO-K1, ATCC CCL 61) derivative, CHOtTA, was
cultivated in ChoMaster HTS (Cell Culture
Technologies, Gravesano Switzerland) supplemented
with 5% fetal calf serum (FCS; Pan Biotech GmbH,
Aidenbach Germany, Cat. No. 3302-P231902, Lot No.
P231902) and 1% (v/v) penicillin/streptomycin solution
(Sigma, St Louis USA, Cat. No. P4458). Cells were
always cultivated in a humidiﬁed 5% CO2,3 7  C incuba-
tor. CHOtTA, containing pDG178 (PhCMV*-1-tTA-pA),
was created by co-transfecting pDG178 and pPUR
(PSV40-Puro
r-pA; Clontech) in a 15:1 ratio into wild-type
CHO-K1 followed by a 2-week cultivation in puromycin-
containing media (Calbiochem, Israel, Cat. No. 540411;
ﬁnal concentration 6mg/ml). Integration of the pDG178
expression cassette and suitability of tetracycline induc-
tion kinetics, of single-cell clones obtained by limiting
dilution, were tested by transient co-transfection with
pMF111 (PhCMV*-1-SEAP-pA) followed by tetracycline
dose proﬁling of SEAP reporter gene expression. Clone
27, exhibiting an induction ratio in excess of 100-fold,
was selected for all further work and designated
CHOtTA. Transfection of plasmid DNA expression
vectors was performed using FuGENE6 transfection
reagent (Roche, Mannheim Germany, Cat. No.
11814443001), according to the manufacturer’s instruc-
tions. The regulating antibiotics tetracycline (Sigma
Chemicals, St. Louis USA, Cat. No. T3383),
pristinamycin 1 (Sanoﬁ-Aventis Inc., Pyostacin, Zurich
Switzerland) and erythromycin (Fluka, Buchs
Switzerland) were prepared as previously described stock
solutions (37).
For experiments involving agarose gel overlays CHO
cells were initially cultivated, seeded and transfected as
described above. Six hours post-transfection, media was
withdrawn and substituted with freshly prepared media
containing 2% low melt agarose (PeqGold, Erlangen
Switzerland, Cat. No. 35-2010), that was prepared accord-
ing to the manufacturer’s instructions. A tetracycline con-
centration gradient was subsequently established by
pipetting tetracycline stock solution onto 6.5-mm blank
absorbent discs (Mast Group, Merseyside UK, Cat. No.
BD0638W) that were placed on top of the set agarose.
Quantiﬁcation of reporter gene expression
Production of human placental-secreted alkaline
phosphatase (SEAP) was quantiﬁed using a
p-nitrophenylphosphate-based light absorbance kinetic
assay as previously described (38,39) with results ex-
pressed in units per litre (U/L). Fluorescence microscopy
tTA PhCMV*-1 pDG178
PSV40 SEAP pSEAP2-
Control
PhCMV GFP pLEGFP-N1
PhCMV*-1 SEAP pMF111
PhCMV*-1 Ubv76-GFP pDG295
PETRON SEAP pWW56
PETRON Ubv76-GFP pND9
PPIRON SEAP pMF208
PhCMV*-1 Pip pDG202
PhCMV*-1 Pip-KRAB pDG205
E PhCMV*-1 pDG218
E-KRAB PhCMV*-1 pDG200
E PPIRON pDG237
E-KRAB PPIRON pBP62
Pip PETRON pDG238
Pip-KRAB PETRON pBP92
Figure 1. Schematic illustration of plasmid expression constructs used in this study. E, E. coli-derived repressor of the macrolide resistance gene
mphA; E-KRAB, macrolide-dependent transsilencer; ETR, operator sequence speciﬁc for E binding; GFP, enhanced green ﬂuorescence protein;
KRAB, human kox-1 gene transcriptional silencer; PETRON, macrolide-responsive ON-type promoters containing eight ETR modules downstream
of PSV40 constitutive promoter; PhCMV, constitutive human cytomegalovirus immediate early promoter; PhCMV*-1, tetracycline responsive promoter
containing seven TetO modules upstream of PhCMVmin;P hCMVmin, minimal PhCMV; Pip, S. coelicolor-derived repressor of the streptogramin resistance
operon; Pip-KRAB, streptogramin-dependent transsilencer; PIR, operator sequence speciﬁc for Pip binding; PPIRON, streptrogramin-responsive
ON-type promoter containing three PIR modules downstream of PSV40;P SV40, constitutive simian-40 virus derived promoter with ESV40; SEAP,
human placental secreted alkaline phosphatase; TetO, operator sequence speciﬁc for TetR binding; TetR, E. coli-derived repressor of the TN10
tetracycline resistance operon; tTA, tetracycline-dependent transactivator (TetR-VP16); Ub
v76, Proteasome targeting substrate; Ub
v76-GFP, Ub
v76
tagged GFP; VP16, Herpes simplex virus-derived transcriptional activator.
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escence microscope (Leica Microsystems DMI 6000B,
11888107) equipped with a DFC350FX R2 digital
camera (Leica, Cat. No: 112730043), a 10  objective
(Leica, Obj. HC PL FL 10x/0.30 PH1 -/D 11.0, Cat.
No. 11506507) and an excitation/emission ﬁlter set for
488/509nm (B/G/R, Cat. No. 11513886). Adjoining
images were assembled into larger mosaic strips,
enabling a complete view across the diameter of a single
well of a 6 well plate, using LAS AF imaging software
(Leica FW4000-TZ, Cat. No. 12723979).
Modelling
Model equations were solved using the simulation
program Berkeley Madonna (www.berkeleymadonna.
com). Machine implementable versions of the equations
used in this study can be accessed at http://mfdata.ethz
.ch/Model_Equations.doc.
RESULTS AND DISCUSSION
Rational design of a band-pass network
To design a network capable of responding to an inducer
within a given concentration range, it is necessary to
engineer modular components that enable the detection
of a low-threshold (point at which target gene expression
is triggered), a high-threshold (point at which expression is
muted) and, of course, a means of integrating the two
detection thresholds. A generic synthetic biologic circuit,
involving multiply linked trans-activator and -repressor
control systems, was designed to reﬂect this functional
criteria.
A constitutively expressed TA, which triggers PTA-
driven expression of a gene product in response to a
small molecule inducer (Ab), was selected as the
common input sensing point of the system. In a typical
gradated conﬁguration, whereby a gene of interest (GOI)
is placed immediately downstream of PTA, increasing Ab
concentrations progressively switches GOI expression off
(Figure 2A). To create a signal inverting function, and
thereby create the low-threshold sensing module, a
transrepressor (TR1) was substituted under PTA-control.
TR1 then represses PTR1/3-driven expression of the GOI.
At low Ab concentrations, TA drives TR1 expression
which represses GOI expression. Conversely, at high Ab
concentrations, TR1 expression is inactivated, the absence
of which results in GOI expression (Figure 2B). The
high-threshold sensing module was created by placing an
additional transrepressor (TR2) under PTA-control, which
represses PTR2-driven expression of a third transrepressor
(TR3). TR3 also controls PTR1/3-driven expression, but
with differing efﬁcacy than TR1. The high-threshold
module involves a double cascade of two inverting func-
tions, thereby providing a mechanism for switching
off gene expression in response to elevated Ab levels
(Figure 2C).
Placed together, the two modules create a network in
which GOI expression is repressed at low Ab concentra-
tions, through TR1 expression and also at high Ab con-
centrations, through TR3 expression. The key to switching
on gene expression, and creating a functional band-pass, is
to separate the Ab boundaries at which the low- and
high-threshold sensing modules operate. By doing so, it
is possible, at an intermediate Ab concentration, to
reach a balance between sufﬁciently low expression of
TR1, to prevent TR1-mediated repression of PTR1/3 and
sufﬁciently high expression of TR2 to prevent TR3 expres-
sion, and consequent TR3-mediated repression of PTR1/3
(Figure 2D). The key parameters that impact whether the
system will exhibit band-pass properties are the relative
activities of the interacting components.
Qualitative model
To conduct a qualitative analysis of this circuit topology
we derived a dimension-less mathematical model to
simulate concentrations and interactions between the
various modular elements.
Constitutive expression of the common ‘input sensing’
TA can be simply described, (PCON and DegTA describe
production and degradation rate, respectively) and is
expected to rapidly reach steady state concentrations
once the degradation rate equals the production rate
(d(DT)/dt=0) [Equation (1)]:
dðTAÞ
dt
¼ PCON   DegTA
 TA ð1Þ
The impact of TA upon subsequent events is determined
by the degree to which TA is activated (TAa) which is a
function of the input [Ab] concentration, and KAB which
represents the inverse concentration at which 50% of TA
molecules are in their activated conformation [Equation
(2)].
TAa ¼ TA   1  
KAB   Ab ½ 
1+ KAB ð  Ab ½  Þ
 
ð2Þ
PTA-driven expression of TR1 [Equation (3)] and TR2
[Equation (4)] follows TA-based Monod kinetics (22)
which is dependent upon (i) PTA maximum velocity
(PTA), (ii) basal, or leaky expression in the absence of
TA, of PTA (1/a), (iii) the relative concentration of TAa
whose affect is described by the Hill-coefﬁcient term, in
which the exponent 2 reﬂects co-operating binding of TA
dimers to their palindromic binding sites with KTA
describing the inverse TAa concentration at which PTA
reaches 50% of maximum velocity. Degradation rates
for TR1 and TR2 are described by DegTR1 and DegTR2
respectively:
dðTR1Þ
dt
¼ PTA
  1
a
+
KTA
 ½TAa  ðÞ
2
1+ KTA
 ½TAa  ðÞ
2

 DegTR1
 TR1
ð3Þ
dðTR2Þ
dt
¼PTA
  1
a
+
KTA
 ½TAa  ðÞ
2
1+ KTA
 ½TAa  ðÞ
2

 DegTR2
 TR2
ð4Þ
PTR-driven expression of either the downstream repressor
TR3 [Equation (5)] or GOI Equations (6) and (7) follows
TR-based expression kinetics (22) and is dependent upon
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PTR1–3 (1/r1–3) and (iii) the relative concentration of TR1–3
whose affect is described by the Hill-coefﬁcient term, in
which the exponent 4 again reﬂects cooperative binding of
TR, and KR1–3, which describes the inverse TR1–3 concen-
trations at which PTR1–3 reaches 50% of maximum
velocity, respectively (40). To differentiate between GOI
expression driven by the low- and high-threshold modules,
and to enable manipulation of their interacting compo-
nents, separate equations were described for each [GOIL
(Equation (6); GOIH (Equation (7)].
dðTR3Þ
dt
¼PTR2
  1
r2
+1  
KR2
 TR2 ðÞ
4
1+ KR2
 TR2 ðÞ
4
  
 DegTR3
 TR3
ð5Þ
dðGOILÞ
dt
¼PTR1
  1
r1
+1  
KR1
 TR1 ðÞ
4
1+ KR1
 TR1 ðÞ
4
  
 DegGOI
 GOIL
ð6Þ
dðGOIHÞ
dt
¼PTR3
  1
r3
+1  
KR3
 TR3 ðÞ
4
1+ KR3
 TR3 ðÞ
4
  
 DegGOI
 GOIH
ð7Þ
Total GOI expression was provided by aggregating GOIL
and GOIH [Equation (8)].
GOI ¼ GOIL+GOIH ð8Þ
For numerical analysis of Equations (1–8), experimentally
determined constraints were used where possible to specify
TA PTA PTA GOI
A
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R
e
s
p
o
n
s
e
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TA PTA PTA TR2
D
Ab
PTR1/3 GOI
PTR2 TR3
PTA TR1
R
e
s
p
o
n
s
e
TA PTA PTA TR2
C Ab
R
e
s
p
o
n
s
e
[Ab]
PTR1/3 GOI
PTR2 TR3
[Ab]
R
e
s
p
o
n
s
e
[Ab]
TA PTA
B
Ab
PTR1/3 GOI
PTA TR1
Activation
Repression
Figure 2. Schematic of differing genetic conﬁgurations with expected response proﬁles to varying inducer (Ab) concentrations. In a standard
gradated conﬁguration (A) expression of the gene of interest (GOI) is directly under PTA control which is inﬂuenced, in an inducer-dependent
manner, by the activity and binding-afﬁnity levels of its cognate transactivator (TA). Within the single cascade conﬁguration (B), PTA is used drive
expression of a repressor (TR) that prevents GOI expression from a TR-dependent PTR promoter. In the absence of TR, as occurs during induce
presence, PTR-driven expression is enabled, thereby inverting the standard gradated signal. The double cascade conﬁguration (C) is similar but
involves the serial insertion of an additional repressor and repressor-dependent promoter downstream of the ﬁrst repressor. Double inversion of the
inducer signal results in a response proﬁle with similar shape but shifted response mid-point to the original gradated signal. The band-pass (D)
conﬁguration simply represents the combination of the single and double-cascade conﬁgurations in which the end repressor of both cascades are
cognate for the same GOI-driving promoter.
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were arbitrarily initially set at 10. Degradation rates
(DegTA, DegTR1–3 and DegGOI) were set to 10
 4 of the
relevant expression-controlling promoter (21). Leakiness
terms (a, and r1–3) were initially set at 32 consistent with
the typical observed leakiness of mammalian gene expres-
sion systems (41). Given the promoter and degradation
assumptions the Michaelis–Menton constants (KTA and
KTR1–3) were initially set at 10
 3 (21). Finally, KAB was
arbitrarily set at 0.02.
Initial simulations focused upon understanding the
relative sensitivity of the ﬁrst downstream expression
product, TR1, to changes in a, PTA and KTA constants
(Figure 3A–C), whereas changes in leakiness impacted
residual and maximal gene expression by a ﬁxed
amount, thereby signiﬁcantly impacting induction charac-
teristics, changes in promoter strength altered both
residual and maximal gene expression proportionately,
thereby only inﬂuencing the quantum of gene product
produced and not the induction window. In terms of par-
ameters impacting dose–response characteristics the KTA
parameter was clearly the most critical. Increasing the ac-
tivation threshold of TTa for its cognate promoter, PTA,
by decreasing the response mid-point of the cognate
promoter (i.e. decreasing K constant), shifted the induc-
tion threshold to the left (i.e. decreasing [Ab] threshold).
Conversely, decreasing the activation threshold (i.e.
increasing K constant) had the opposite effect and
shifted the induction threshold to the right. These initial
simulations suggested that one could optimize detection
thresholds for low- and high-detection componentry by
altering K constants. Further simulations on GOI expres-
sion driven by the low- and high-threshold detecting com-
ponents corroborated this hypothesis (Figure 3D and E),
whilst providing important constraints regarding the re-
quirement for downstream K constants to possess an ap-
propriate response mid-point (i.e. not lower than
K=0.001), with the relative response mid-point of the
upstream K constant determining the threshold shift.
Selection of downstream K constants without the appro-
priate response mid-point negatively impacted the func-
tionality of the respective threshold detection system.
A C
B D
Figure 3. In silico analysis of the synthetic band detection componentry. In each case, dose–response proﬁles in response to varying concentrations of
inducer antibiotic [(Ab)] were modelled using parameters described in results section. Impact of changes in PTA leakiness (input a)( A), PTA promoter
strength (B), and the Michaelis–Menten constant KTA (C), on expression read-out of the ﬁrst downstream repressor TR1.( D) Impact of differing
ratios of the Michaelis–Menten constants, KTA and KTR1, on GOI expression from the low-threshold detection componentry [GOI (low)]. (E) Impact
of differing ratios of the Michaelis–Menten constants, KTA, KTR2 and KTR3, on GOI expression from the high-threshold detection componentry [GOI
(high)]. (F) Kinetic evolution of band-pass network driven expression of GOI (total) at differing time points (arbitrary time units) in which
parameters for low (KTA=0.0001; KTR1=0.001)- and high-threshold componentry (KTA, KTR2, KTR3=0.001) have been selected for optimal
performance. (G,H) Kinetic evolution of low- (G) and high- (H) threshold detection componentry at differing time points (arbitrary time units)
using the same optimized parameters.
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detection thresholds for the low- and high-detection
componentry resulted in functional band-detection
networks (Figure 3F). Time-course analysis indicated
that the appearance of band detection characteristics
would not be immediate, but would be a function of the
delay due to the transcriptional cascades inherent to both
the low- and high-threshold detection componentry,
with the longer delay occurring for the high-threshold
(Figure 3G and H).
Taken together, these simulations indicated that the
emergence of band-pass characteristics would be highly
dependent upon ﬁne-tuning of the various cascade
elements. Signiﬁcant factors include: (i) the importance
of tight induction ranges, and minimal leakiness, for all
systems within the cascade. While leakiness interferes with
network performance at any stage of the cascade, this is
most critical for upstream components as any leakiness
there cannot be ‘recovered’ through subsequent tighter
downstream components. (ii) Relative promoter strengths
are notionally important, but given changes in promoter
strength impact both residual and maximal expression
equally, this is less critical than changes in other param-
eters. (iii) The concentration of regulator at which the re-
spective cognate promoter is activated (designated by
Michaelis–Menton constants) is critical in determining
the inducer concentration range within which the speciﬁed
system responds. Signiﬁcantly, these simulations suggested
that changes in the relative response mid-points of gene
control systems could be exploited to create low- and
high-threshold detecting modules that operated at differ-
ing inducer concentrations; a necessary pre-condition
for the formation of viable band-detection networks.
Moreover, by tailoring response mid-points for both
low- and high-threshold componentry it would be
possible to ﬁne-tune the response range of the system
both in terms of the ‘range’ over which the system
responds as well as the exact concentration at which it
produces maximal expression.
In vivo implementation of band-pass network in
CHO cells
Recent advances in the development of inter-operable
mammalian gene control systems provide the opportunity
to test the above mathematical predictions by linking
together different systems that possess differing regulation
characteristics (42). To construct a mammalian band-pass
network, the tTA (20), E-ON (29) and Pip-ON (30) heter-
ologous gene control systems were selected.
Tetracycline-sensitive tTA was selected as the ‘input’
sensing point of the system which controlled expression,
via a tTA responsive promoter (PhCMV*-1), of either the
H G
F E
Figure 3. Continued.
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dependent transrepressor Pip. Expression plasmids were
selected in which the repressor could be expressed in its
nascent form (E; pDG218, Pip; pDG202) or conjugated to
a KRAB transcription silencing domain (E-KRAB;
pDG200, Pip-KRAB, pDG205). For the low-threshold
sensing module, the system’s output was monitored via
reporter gene expression (SEAP) which was placed
under expression control of the respective PETRON or
PPIRON promoters (pWW56 and pMF208, respectively).
The high-threshold detection module was created by
introducing a serially linked secondary repressor into
one of the low-threshold sensing modules to create a
two-step cascade. For this purpose, the secondary repres-
sor (E, E-KRAB, Pip or Pip-KRAB) was placed under
expression control of the respective PPIRON or PETRON
promoter (pDG237, pBP62 and pDG238, pBP92,
respectively).
Given the model requirements for a tightly controlled,
but relatively wide induction window for the ‘input
sensing’ tTA module, a stable cell line expressing tTA in
an autoregulated manner from its own cognate PhCMV*-1-
driven promoter (CHOtTA containing pDG178) was con-
structed. While the use of an autoregulated construct
reduced maximal gene expression, it signiﬁcantly reduced
‘leakiness’, thereby increasing the effective induction range
(33). It additionally minimized the inﬂuence of extraneous
noise on the system (43). Transient transfections of
CHOtTA with a PhCMV*-1-driven SEAP reporter gene
(pMF111) conﬁrmed an induction range in excess of
100-fold. ON to OFF gene expression was mediated
most signiﬁcantly between tetracycline (Tet) concentra-
tions of 10 and 50ug/ml (Figure 4).
Initial experiments to construct the band-pass network
focused on determining the relative differences in reporter
gene expression levels for different combinations of re-
pressors (E, E-KRAB, Pip and Pip-KRAB) for both the
low- and high-threshold detection components (Figure 5).
Differences in the inherent ability of E and Pip to repress
expression from their cognate promoters (PETRON and
PPIRON, respectively) were reﬂected in the differing induc-
tion characteristics of the various low-threshold conﬁgur-
ations (Figure 5A). In both its native form, and when
fused with the KRAB transcriptional silencer domain,
Pip was a stronger repressor than E, as evident by
comparing SEAP expression in the absence of Tet.
However, this was also reﬂected in lower maximal expres-
sion levels, which occurred in the presence of Tet, which
were caused by residual repression of the respective repres-
sor from their PhCMV*-1-driven promoters. Coupling each
repressor with the KRAB domain signiﬁcantly
exacerbated this affect (29,30). Taken together, the
E-KRAB and native Pip utilizing conﬁgurations
provided the greatest dynamic induction range.
Accordingly, these conﬁgurations were further used to de-
termine the optimal conﬁguration for the high-threshold
componentry.
Two sets of high-threshold conﬁgurations were tested
for each of E-KRAB and native Pip. In the ﬁrst set,
PhCMV*-1-driven E-KRAB (pDG200) was linked to
PETRON-driven expression of either Pip (pDG238) or
A
B
Figure 5. Conﬁguration testing of low-threshold (A) and
high-threshold (B) detection components. In all cases, CHOtTA
(PhCMV*-1-tTA) cells were transiently transfected with indicated con-
structs and grown in the presence or absence of 1mg/ml tetracycline
(Tet).
Figure 4. Tetracycline (Tet) dose–response proﬁle of CHOtTA (PhCMV*-
1-tTA) transiently transfected with pMF111 (PhCMV*-1-SEAP-pA).
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PPIRON-driven SEAP expression (pMF208). In the
second set, PhCMV*-1-driven Pip (pDG202) was linked to
PPIRON-driven expression of either E (pDG237) or
E-KRAB (pBP62), with corresponding ﬁnal read-out
provided by PETRON-driven SEAP expression
(pWW56). Of these conﬁgurations, only the second set,
with native Pip as intermediary repressor, resulted in dir-
ectionally correct readout for a double inversion function
in which SEAP expression was reduced in the presence of
Tet (Figure 5B). Of these, the Pip to E-KRAB cascade
resulted in the greatest fold decrease, compared to the
conﬁguration utilizing E as the secondary repressor.
Signiﬁcantly these conﬁgurations either did not exhibit
the double inversion function (E-KRAB to Pip cascade),
or resulted in non-expression irrespective of Tet presence
(E-KRAB to Pip-KRAB cascade). These results are con-
sistent with model predictions in which a double inversion
is dependent upon the strength of the intermediary repres-
sor (TR2) relative to the secondary repressor (TR3) (see
also Figure 3E). Critically, an intermediary repressor that
represses too tightly will not result in inversion of the
input signal as the resulting K constants for the respective
systems would not be sufﬁciently far apart.
Based on these initial componentry observations, a
putative band-pass network was tested by utilizing
E-KRAB as the low-threshold TR1 repressor, and Pip
and E-KRAB as the TR2 and TR3 high-threshold repres-
sors, respectively (Figure 6A). In this arrangement, the
ﬁnal repressors of each threshold (TR1 and TR3)
operated on the same cognate promoter (PETRON) to
drive SEAP expression. Expression proﬁling across a Tet
concentration gradient revealed an expression read-out in
which SEAP expression was repressed at Tet concentra-
tions below 25ng/ml; and again at concentrations above
250ng/ml, indicating that the low and high-threshold
componentry were inter-operable (Figure 6B).
Signiﬁcantly, at intermediate concentrations SEAP ex-
pression increased to levels that were  5- and 2-fold
greater than at the respective lower and upper Tet concen-
tration ranges. Override of both the low- and
high-component thresholds, through the addition of the
E-KRAB responsive inducer erythromycin, resulted in
SEAP expression of 8.49U/L (±1.36U/L) which was
A
B
Tet
tTA PhCMV*-1
CHOtTA
E-KRAB PhCMV*-1
PhCMV*-1
E-KRAB PPIRON
PETRON SEAP Pip
pDG200
pDG202
pBP62
pWW56
Figure 6. (A) Schematic depiction of band-pass network including both low- and high-threshold componentry. (B) Tetracycline (Tet) dose–response
proﬁle of CHOtTA transiently transfected with band-pass network componentry pDG200, pDG202, pBP62 and pWW56.
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suggests some degree of repression, from either the low or
high componentry, was in existence across the entire Tet
concentration range with the observed positive band-pass
expression pattern reﬂecting the existence of an intermedi-
ate Tet concentration range in which the low-threshold
componentry depression was not completely offset by
activated repression of the high-threshold componentry.
Network optimization of band-pass characteristics
As both low- and high-componentry characteristics, and
the resulting band-pass network, are dependent upon the
relative repression characteristics of the underlying com-
ponents, we sought to further optimize the band-pass
network by altering plasmid ratios during transfection.
Decreasing the relative expression level of E-KRAB
within the low-threshold componentry (by reducing
pDG200 during transfections) resulted in an increase in
de-repressed maximal SEAP expression with a relatively
lower increase in fully repressed SEAP expression
(Figure 7A). This was manifested most when the ratio of
SEAP reporter plasmid (pWW56) to E-KRAB expressing
plasmid (pDG200) reached 5 to 1 at which point maximal
expression had increased 81% with only a 41% increase in
residual expression (resulting in a differential expression
of 11-fold). Beyond this ratio, maximal SEAP expression
did not signiﬁcantly increase while repressed SEAP ex-
pression did, thus indicating that at higher than 5:1
ratios E-KRAB was present in insufﬁcient quantity to ef-
fectively repress PETRON-driven SEAP expression.
Similar experiments performed on the high-threshold
componentry revealed that the dynamic expression range
could also be expanded by reducing upstream components
on the double repressor cascade (Pip and E-KRAB)
(Figure 7B). An optimal expression range was evidenced
at a PETRON-SEAP to PPIRON-E-KRAB to PhCMV*-1-Pip
ratio of 4:2:1. In a ﬁnal optimization step, the optimized
low-and high-threshold components were combined in dif-
fering ratios to test which produced the most robust
band-pass functionality (Figure 7C). Of the three combin-
ations tested, the 1:1 combination produced the most
balanced band-pass functionality with peak SEAP expres-
sion of 8.7U/L (±0.6U/L) at 50ng/ml which was 6- and
4-fold higher than SEAP expression at low (0) and high
(1000ng/ml) Tet concentrations, respectively. The other
two combinations also produced band-pass functionality
but with expression proﬁles that reﬂected the relative con-
centration difference of each threshold component. Thus,
a higher concentration of low-threshold components
produced an expression proﬁle in which SEAP repression
was effective at low Tet concentrations but less so at
high Tet concentrations. The opposite occurred when
high-threshold components were expressed at relatively
higher concentrations. Differences in the Tet concentra-
tion at which peak SEAP expression occurred were also
evident between the different combinations with stronger
low-threshold componentry drawing the peak lower and
vice versa for stronger high-threshold componentry. The
ability to alter the sensing capability of the system to
either expands its dynamic range or move its maximal
sensing point suggests that the system is amenable to
being tuned to differing input concentrations.
Kinetic evolution of band-pass functionality
The existence of an intermediate Tet concentration range,
in which the low-threshold componentry depression was
A
B
C
Figure 7. Ratio optimization of band-pass components and network.
(A) Low-threshold performance assessed by varying target gene
controlling E-KRAB (pDG200; PhCMV*-1-E-KRAB) plasmid concentra-
tion while maintaining target gene encoding plasmid
(pWW56; PETRON-SEAP) at ﬁxed concentration. (B) High-threshold
performance assessed by varying PPIRON controlling Pip
(pDG202; PhCMV*-1-Pip), and target gene controlling E-KRAB
(pDG200; PPIRON-E-KRAB), plasmid concentrations while maintain-
ing target gene encoding plasmid (pWW56; PETRON-SEAP) at ﬁxed
concentration. (C) Band-pass performance assessed by varying ratio
of total low-threshold optimized componentry (0.2:1;
pDG200:pWW56) to total high-threshold optimized componentry
(0.25:0.5:1; pDG202:pBP62:pWW56).
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high-threshold componentry, could only occur if
de-repression of the low-threshold componentry
occurred at a faster rate or lower Tet concentration than
activated repression of the high-threshold componentry.
To further explore the underlying dynamic driving this
outcome, a kinetic study of the optimized band-pass
network was performed (Figure 8). Expression proﬁling
revealed differences in the Tet concentration range
within which expression switching occurred. Whereas in-
duction from the low-threshold componentry occurred
consistently around 50ng/ml Tet (Figure 8A), effective
repression from the high-threshold componentry
occurred at lower Tet concentrations earlier during the
time course compared to later in the time course
(Figure 8B). A similar shift was observed for the
band-pass network (Figure 8C) in which positive
band-pass behaviour only became observable from 24h
onwards. However, at this time point, the band peak
was manifested at a lower Tet concentration (50ng/ml)
compared to 36h and beyond where it stabilized at
around 100ng/ml. This is consistent with modelling pre-
dictions due to the ‘lag’ time inherent to the double-level
high-threshold cascade being longer than that of the single
level low-threshold cascade (Figure 3G and H).
Spatio-temporal band formation in CHO cells
We next sought to assess whether the optimized band-pass
network could respond to a mock ‘morphogen-like’
gradient to produce a differentiation-like pattern across
a layer of CHO cells (Figure 9). In an adaptation of the
Kirby–Bauer Disc Diffusion Methodology, a uniform
transfected layer of CHO cells were exposed to a tetracyc-
line concentration gradient which was established by
cultivating the cell layer in solidiﬁed culture media, and
allowing known aliquots of tetracycline to diffuse through
the solid media (44). Using an Ub
v76 destabilized variant
of GFP as the target reporter gene it was possible to
discern differences in expression levels, for both standard
gradated gene control (Figure 9D) and for the low and
high thresholds and for the complete band-pass network,
in response to physical cellular position along the concen-
tration gradient (Figure 9E–H). Signiﬁcantly, by altering
the concentration of tetracycline initially applied, and
therefore changing the strength of the concentration
gradient, it was possible observe differences in band for-
mation position therefore indicating that the network was
capable of detecting a speciﬁc inducer concentration
within a gradient. Identical experiments using native
GFP also produced similar patterns, although these were
less discernible from background GFP expression levels
(data not shown). Given the shorter half-life of Ub
v76
destabilized GFP, we suggest that it more accurately
reﬂects the expression status of a cell at any given point
along the concentration gradient thereby producing a
more discernable pattern from background expression
levels.
In this study, we have designed a synthetic gene network
that is capable of detecting intermediate concentrations of
a stimulus molecule. The system utilized multiple
well-known transcriptional control modalities which
were selected and optimized in their interaction with one
another to produce the requisite band-pass characteristics.
By engineering a mammalian genetic circuitry that is
capable of sensing a speciﬁc concentration within a mor-
phogen gradient we have emulated a mechanism that
serves as a pre-condition for positional-speciﬁcation and
subsequent organized pattern formation. We see the
design of this and similar systems as critical steps
towards creating designer cells and tissues that will
A
B
C
Figure 8. Kinetic study of target gene expression at 15, 26, 39 and 48h
post-transfection of optimized low-threshold (A), high-threshold (B)
and band-pass network (C) components. Dose–response proﬁle at
varying tetracycline (Tet) concentrations depicted.
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and bioprocessing applications.
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